RecruitingLeukemia, AcuteMDS
Frailty Phenotype Assessments to Optimize Treatment Strategies for Older Patients With Hematologic Malignancies
Eligible age
60+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The purpose of this research study is to determine if frailty assessments can be used to predict how well patients aged 60 years and older will do after chemotherapy, CAR T-cell therapy, or allogeneic stem cell transplant.
Sponsor: Abramson Cancer Center at Penn Medicine
Where it's recruiting
Pennsylvania
Philadelphia
Source: ClinicalTrials.gov · NCT03680677 · last updated 2025-07-31